Astrazeneca Pharma India Share Price
6971.00+30.50 (+0.44%)
-23.35% past 1 Year
News
AstraZeneca Pharma India to hold analyst and investor meet on August 19
Equity
ASTRAZEN
AstraZeneca Pharma reports Q1 revenue rises to Rs 680 crores
Equity
ASTRAZEN
AstraZeneca Pharma reports lower Q1 EBITDA and margin year on year
Equity
ASTRAZEN
AstraZeneca Pharma reports lower Q1 net profit year on year
Equity
ASTRAZEN
Astrazeneca gains India approval for Enhertu in early-stage breast cancer
Equity
ASTRAZEN
Astrazeneca Pharma India CFO Bhavana Agrawal resigns for regional group role
Equity
ASTRAZEN
AstraZeneca Pharma receives CDSCO approval for Benralizumab import and sale
Equity
ASTRAZEN
AstraZeneca Pharma India appoints Praveen K Mittal as corporate affairs director
Equity
ASTRAZEN
AstraZeneca Pharma India informs about resignation of senior management personnels
Equity
ASTRAZEN
Astrazeneca Pharma India loses two senior executives in June 2026
Equity
ASTRAZEN
AstraZeneca Pharma India informs about updates
Equity
ASTRAZEN
Astrazeneca Pharma India gets nod to import, market cancer drug in India
Equity
ASTRAZEN
AstraZeneca Pharma India recommends Rs 36 dividend per share
Equity
ASTRAZEN
Astrazeneca Pharma Q4 EBITDA declines sharply with margin compression YoY
Equity
ASTRAZEN
Astrazeneca Pharma Q4 FY Earnings Show Profit Decline Despite Strong Revenue Growth
Equity
ASTRAZEN
Astrazeneca Pharma I reports Profit after tax of 44.88 Crores, in the March 2026 quarter
Equity
ASTRAZEN
Astrazeneca Pharma India gets nod to import Acalabrutinib tablets for new oncology use
Equity
ASTRAZEN
Astrazeneca Pharma India gets CDSCO approval expanding Calquence lymphoma use
Equity
ASTRAZEN
AstraZeneca Pharma partners Roche Diagnostics to advance cancer pathology in Singapore
Equity
ASTRAZEN
AstraZeneca Pharma surges on getting nod to import, market Acalabrutinib tablets 100 mg
Equity
ASTRAZEN